G9126
HCPCSOnc dx cml remission
Official HCPCS Level II long descriptor
Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
HCPCS Level II code G9126 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx cml remission
Added to HCPCS: 2006-01-01
Nearby codes in G9
- G9113Onc dx ovarian stg1a-b no pr
- G9114Onc dx ovarian stg1a-b or 2
- G9115Onc dx ovarian stg3/4 noprog
- G9116Onc dx ovarian recurrence
- G9117Onc dx ovarian unknown nos
- G9123Onc dx cml chronic phase
- G9124Onc dx cml acceler phase
- G9125Onc dx cml blast phase
- G9128Onc dx multi myeloma stage i
- G9129Onc dx mult myeloma stg2 hig
- G9130Onc dx multi myeloma unknown
- G9131Onc dx brst unknown nos
- G9132Onc dx prostate mets no cast
- G9133Onc dx prostate clinical met
- G9134Onc nhlstg 1-2 no relap no
- G9135Onc dx nhl stg 3-4 not relap
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.